ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wisconsin » Neurology

Top Neurology Prescribers in Wisconsin

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PAUL BARKHAUS MD

Neurology

195

$163K

38
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

68%
prescriptions for brand name drugs

Avg: 22%

$835
Average prescription price

Avg: $206

JOHN PIDGEON MD

Neurology

200

$8,313

37
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

10%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $206

CATHERINE GALLAGHER MD

Neurology

201

$8,288

40
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

0%
prescriptions for brand name drugs

Avg: 22%

$41
Average prescription price

Avg: $206

WILSON CUEVA M.D.

Neurology

252

$62.7K

44
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$249
Average prescription price

Avg: $206

SAFWAN JARADEH MD

Neurology

266

$19.5K

58
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 22%

$73
Average prescription price

Avg: $206

MICHAEL CARRITHERS MD

Neurology

294

$257K

20
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 22%

$874
Average prescription price

Avg: $206

GEORGE BOBUSTUC MD

Neurology

316

$23.2K

55
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 22%

$74
Average prescription price

Avg: $206

MOHAMMAD HEDER M.D

Neurology

329

$27.5K

71
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$83
Average prescription price

Avg: $206

JOANNA GALEZOWSKA MD

Neurology

330

$39.1K

69
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$119
Average prescription price

Avg: $206

THOMAS PERRY M.D.

Neurology

333

$39.3K

36
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

0%
prescriptions for brand name drugs

Avg: 22%

$118
Average prescription price

Avg: $206

THOMAS MARRA MD

Neurology

336

$11.6K

37
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

3%
prescriptions for brand name drugs

Avg: 22%

$35
Average prescription price

Avg: $206

HENDRIKUS KROUWER MD

Neurology

379

$38.5K

54
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 22%

$102
Average prescription price

Avg: $206

SOMCHAI LAOWATTANA MD

Neurology

389

$59K

55
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

8%
prescriptions for brand name drugs

Avg: 22%

$152
Average prescription price

Avg: $206

JENNIFER CONNELLY MD

Neurology

419

$72.5K

87
45 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 22%

$173
Average prescription price

Avg: $206

RALPH FROELICH MD

Neurology

422

$52.8K

39
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 22%

$125
Average prescription price

Avg: $206

MICHAEL LEONE M.D.

Neurology

431

$63.5K

109
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$147
Average prescription price

Avg: $206

BYUNG PARK M.D.

Neurology

439

$109K

106
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$248
Average prescription price

Avg: $206

ELIZABETH MARRIOTT MD

Neurology

449

$98.5K

71
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$219
Average prescription price

Avg: $206

RODNEY SORENSEN DO

Neurology

464

$75.3K

96
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 22%

$162
Average prescription price

Avg: $206

BAREND LOTZ MD

Neurology

486

$29.1K

58
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $206

PHILIP SWEET M.D.

Neurology

539

$55.5K

29
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 22%

$103
Average prescription price

Avg: $206

JOHN FLEMING MD

Neurology

561

$361K

56
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$644
Average prescription price

Avg: $206

OSAMA ZAIDAT MD

Neurology

582

$49.2K

99
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$85
Average prescription price

Avg: $206

HARVEY BLOCK MD

Neurology

598

$98.8K

89
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$165
Average prescription price

Avg: $206

LINGA REDDY M.D., PH. D.

Neurology

602

$96.7K

145
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 22%

$161
Average prescription price

Avg: $206

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank